MM

Muhammad Muneer Kuttikkattil

Active Director Director DIN 10281154
DIN 10281154 First appointment Aug 2023
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Muhammad Muneer Kuttikkattil

Data last updated:

Muhammad Muneer Kuttikkattil is a Director at Zycox Pharma Private Limited (since 2023) and Director at Bacox Pharma Private Limited (since 2023).

DIN 10281154
Primary Designation Director
First Appointment 17 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zycox Pharma Private Limited U46497KL2023PTC083936
Director11 Oct 20232023Active
Bacox Pharma Private Limited U46497TZ2023PTC029185
Director17 Aug 20232023Active

Board colleagues of Muhammad Muneer Kuttikkattil

Directorship timeline

Open interactive timeline →
Zycox Pharma Private Limited
Bacox Pharma Private Limited
Premium access

Shareholding and investment profile for Muhammad Muneer Kuttikkattil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muhammad Muneer Kuttikkattil

Muhammad Muneer Kuttikkattil currently holds 2 directorships: Zycox Pharma Private Limited (Director, since 11 Oct 2023); Bacox Pharma Private Limited (Director, since 17 Aug 2023).

Muhammad Muneer Kuttikkattil was first appointed on 17 Aug 2023 as Director at Bacox Pharma Private Limited.

The current boards of Muhammad Muneer Kuttikkattil's companies include Valapra Alshad Ali (Zycox Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available